Health

MGI COVID-19 Container Lab Put to Test, Safeguarding the World Figure Skating Championships

STOCKHOLM, April 13, 2021 /PRNewswire/ -- The weeklong ISU World Figure Skating Championships (the Championships), an Olympic qualification event, were held in Stockholm, Sweden in late March. The world's top figure skaters from around the world had travelled toSweden to compete for the title of w...

2021-04-13 14:32

Psychobiotic PS128 improves mood and sleep quality in its first clinical study on anxiety and stress

TAIPEI, April 13, 2021 /PRNewswire/ -- Bened Biomedical's psychobiotic PS128 significantly improved insomnia, stress, and anxiety during a recent clinical trial. Participants were IT professionals under high levels of work-life stress. Psychobiotics are probiotics that yield specific mental healt...

2021-04-13 10:00 381

Zuellig Pharma Clinches Ecovadis Gold Medal 2021 For Sustainability

SINGAPORE, April 13, 2021 /PRNewswire/ -- Zuellig Pharma, a leading healthcare services provider inAsia has been awarded the Gold Medal 2021 from sustainability ratings specialistEcoVadis . Zuellig Pharma ...

2021-04-13 09:00 470

Ascentage Pharma Releases Preclinical Data of Its Core Drug Candidates at AACR Annual Meeting 2021, with Results Signifying the Potential of Multiple Combination Therapies in Cancer

SUZHOU, China and ROCKVILLE, Md., April 13, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented the preclinical results of ...

2021-04-13 08:28 416

Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at AACR 2021

SUZHOU, China, April 13, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from phase Ib/II clinical study (clinical trial No.: KN046-203) of PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel for the treatment of patients with metastatic trip...

2021-04-13 08:15 674

Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021

SAN FRANCISCO and SUZHOU, China, April 13, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-04-13 08:00 689

Antengene Presented Preclinical Data Demonstrating Potent Synergistic Effect of the Combination of ATG-010 (Selinexor) and ATG-008 (Onatasertib) for the Treatment of Triple-Hit DLBCL

SHANGHAI, China and GAITHERSBURG, U.S., April 13, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in h...

2021-04-13 08:00 466

Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year

PALO ALTO, Calif., April 13, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the fourth year in a row. Varian's Net Promoter Score ...

2021-04-13 04:15 681

Island Pharmaceuticals Limited to list on the ASX today following oversubscribed A$7.5m IPO

MELBOURNE, Australia, April 13, 2021 /PRNewswire/ -- Australian antiviral drug development company, Island Pharmaceuticals (Island) is set to list on the Australian Securities Exchange (ASX) today after raisingA$7.5 million through its Initial Public Offer (IPO) which was significantly oversubscr...

2021-04-13 04:00 958

Hospital at Home Care Set to Make it Big in the United States with Strong Support from the Government

Adoption of HaH model surged eight-fold in less than six months with the availability of advanced remote monitoring and digital health solutions, finds Frost & Sullivan SANTA CLARA, Calif., April 13, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Payment Reforms and Remote Care Deliver...

2021-04-13 00:30 675

Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients

LEUVEN, Belgium, April 12, 2021 /PRNewswire/ -- Terumo is proud to announce the launch of its Global Therapeutic Interventional Oncology team as ofApril 1st, 2021. This reflects Terumo's aspiration to be a Global leader in the field of Interventional Oncology by focusing on improving patient's qu...

2021-04-12 22:25 1121

Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic

* Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month SEOUL, South Korea, April 12, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology company specializing in molecular diagnostics, announced today that it has secured an export ...

2021-04-12 20:53 1084

PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021

DAEJEON, South Korea, April 12, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring the non-clinical data of PMC-309 at American Associatio...

2021-04-12 20:00 520

OOOPDS - a surgical planning software received TFDA Class-II medical device certification developed by Taiwan Main Orthopaedic Biotechnology Co., Ltd.

TAICHUNG, Taiwan, April 12, 2021 /PRNewswire/ -- Taiwan Main Orthopaedic Biotechnology announced today (12) that their OOOPDS 3D medical image reconstruction and surgical planning medical software has received TFDA Class-II certification. OOOPDS is the most comprehensive 3D surgical planning sof...

2021-04-12 19:50 688

Alma, a Sisram Medical Company, Launches Alma PrimeX™, the Ultimate Non-invasive Platform for Body Contouring and Skin Tightening, Delivering Spectacular Results

NURNBERG, Germany, April 12, 2021 /PRNewswire/ -- Alma , one of the global leaders of energy-based medical and aesthetics solutions, unveiled the newAlma PrimeX™ platform today, during a...

2021-04-12 19:30 501

AXA launches "Free Double Post-Vaccination Protection" Programme

HONG KONG, April 12, 2021 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") launches the "Free Double Post-Vaccination Protection" Programme ("Programme") to provide free protection to customers against adverse event following immunisation ("AEFI"). From 1 April to30 June 2021, eligible customers[1...

2021-04-12 17:54 611

SkinPen® Precision Now Under Direct Management in the United Kingdom and Ireland

DALLAS, April 12, 2021 /PRNewswire/ -- Crown Aesthetics, a division of Crown Laboratories, Inc., is delighted to announce that SkinPen Precision, the first microneedling device cleared by the FDA and the gold standard for skin remodeling technology, now has a direct presence in the UK andIreland....

2021-04-12 17:32 460

Yiling Pharmaceutical doubled its performance through innovation in 2020

SHIJIAZHUANG, China, April 12, 2021 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) released its 2020 annual report on Thursday. It achieved an operating revenue ofRMB 8.782 billion in 2020, with a year-on-year growth of 50.76%; and net profit attributed to equity holders ofRMB 1.219 billion, w...

2021-04-12 17:07 1072

Airway Therapeutics Announces FDA Acceptance of IND for AT-100's Second Indication in Severe COVID-19 Patients

Initiating Phase 1b clinical trial with initial results expected 3Q2021 Potential for novel therapeutic AT-100 to inhibit viral replication, promote viral elimination and reduction of lung injury, inflammation, and secondary infections in severe COVID-19 patients CINCINNATI, April 12, 2021 /PRNe...

2021-04-12 16:00 606

GenScript, Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate to provide cPass(TM) SARS-CoV-2 Neutralizing Antibody Testing Service in Singapore

SINGAPORE, April 12, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test inSingapore through Parkway's pane...

2021-04-12 13:00 1499
12345 ... 999